About Us

healtheo360 is a "Caring Community" where patients living with chronic conditions, such as Diabetes, Cancer, Alzheimer's, and many others come to find support, encouragement, and information.

The healtheo360 community includes patients, their caregivers, family members and friends who come to share their personal healing stories so that others may find inspiration and motivation as they go through the journey of living with their condition. Members share their health-related stories and learn from each other through discussion. We encourage you to upload your story via video testimonies but we also offer blogging for those who are more comfortable with that method of sharing. At healtheo360 we believe in the healing power of storytelling and how beneficial it is to share your story as well as to learn from other people with similar experiences.

David Duplay founded healtheo360 in 2013 after his sister-in-law was diagnosed with stage IV breast cancer and his mother with Alzheimer’s disease. After unsuccessful efforts with other support groups, due in part to the widening age gap between members of these groups, the family was forced to search for other outlets of social support. In response, healtheo360 was started.

Our services include Virtual Social Therapy (VST), peer counseling, support groups, educational publications and access to hundreds of videos. All services offered on our site are completely free of charge and every day we are working to raise awareness of all chronic conditions.

Peer Counseling

Members share their personal stories for the entire community to watch and learn from. Comments are allowed and encouraged to promote lively discussions. Share as much or as little as you want and gain new friends who are interested in the same health related topics as you.

Support Groups

Led by community moderators, our support groups allow you to connect with others in similar situations in order to share information and experiences. With over 20 different condition specific groups, and growing, we are constantly striving to make your voice heard. Don’t see your condition listed? Don’t worry! Simply upload your story and a new group will be created specifically for your needs.

Educational Publications

Our reliable and current blog content is designed specifically to teach and engage users with a wide variety of health related news in an entertaining and engaging way. By covering everything from weight management to healthy living with medical imagery, graphics and animation, healtheo360 gives members access to the issues they care most about.


Made by members “Just Like You”, our library of videos are health journals covering symptoms, diagnosis, treatment, remission, and various other health topics. Doctors, patients, caregivers, nurses, family members and friends all play a role in the healtheo360’s caring community.

Our mission is to provide a safe, enjoyable platform that allows you to have an outlet of support when you need it most. healtheo360 will continue to focus on health issues, reliable content and supportive communities that are important to you, your family and friends.

healtheo360 was developed with one purpose in mind - To provide our members with a safe online community to find support, encouragement, inspiration and a sense of belonging.

Real People, Real Stories, Real Life®.


Meet the healtheo360 Leadership Team:

David S. Duplay - Founder, Chairman and Chief Executive Officer

Michael D. Bell, Esq. - Board Member

Robert G. Bell, Ph.D. - Board Member

Timothy J. Foley - Senior Vice President

David Hassrick - Chief Sustainability Officer

Robert Kamerschen - Chairman Emeritus and Partner

Leslie V. Norwalk, Esq. - Board Member

John F. O'Connell, Ph.D. - Chief Technology Officer

Matthew T. Riccio - Healthcare Insights Consultant, National Science Foundation Graduate Research Fellow


David S. Duplay is a business and technology strategist for the pharmaceutical and healthcare industry. With a heritage in healthcare marketing, communications, and technology, David has worked with pharmaceutical companies, the medical profession, research organizations and patient groups for over 20 years, completing various types of marketing and strategy projects across almost all disease areas. 

As an advocate for the healthcare industry and a passionate believer that aligning the goals and aspirations of all stakeholders in healthcare is key to improving outcomes for patients, David is frequently invited to comment on the positive aspects of working with the pharmaceutical and managed care industry and is a recognized author and speaker on healthcare marketing strategies, physician, patient and caregiver strategies as well as the pharmaceutical industries role in delivering quality care. This has included working with large Pharmaceutical and Biotech companies in developing strategic and closed loop marketing programs, developing and implementing eHealth and social media strategies, running workshops, focus groups, advisory boards and global initiatives on topics as far-reaching and politically sensitive as lowering drug prices globally, in addition to developing and implementing managed care and consumer-driven healthcare strategies.  

In 2010, David founded MedTera an integrated marketing solution company focused on the transformation of pharmaceutical, healthcare and life science marking. MedTera is focused on creating solutions that enable clients to optimize their investment in the development, promotion and delivery of their healthcare products and services. MedTera is headquartered in New York City and can be found at: www.medterasolutions.com.

In 2003, David founded New Colony Partners, a healthcare consulting firm dedicated to assisting healthcare and life science companies to: open new markets in the midst of an industry being redefined; integrate patients, providers, payers and pharmaceutical companies in a continuum of healthcare delivery; improve the delivery of professional services such as prescription compliance and persistence; and improve clinical processes and decision making through the utilization of new and innovative technologies. 

Prior to founding New Colony Partners, David has served as general manager for three pharmaceutical marketing services companies: Clark-O'Neill, Physician Desk Reference and Phoenix Marketing Group in developing solutions which contribute to enriching, prolonging and savings people's lives. David is also the founder of eHealthScience.com, an online data reporting and insights company providing marketing intelligence to the Healthcare, Life Science and Pharmaceutical industry. 



Michael D. Bell, J.D.:  Mike’s entire career has been focused on the intersection of healthcare and technology, where most recently, he co-founded and served as President and CEO of R-Squared Services & Solutions, Inc. (now part of QunitilesIMS), which was a SAAS-based compliance software provider to the pharmaceutical and medical device industries.  Prior to that, Michael was a partner at a prestigious Washington, DC law firm where he advised players across the US healthcare sector.


Robert Bell, Ph.D. is President / Owner of Drug and Biotechnology Development LLC, a consultancy to the pharmaceutical industry and academia for biological, drug and device development. Dr. Bell received his B.S. in Chemistry, M.S. in Food Science and Human Nutrition and Ph.D. in Pharmaceutics from the University of Florida. His employment history includes Carter-Wallace, Inc., AL Pharma, UDL Laboratories, Inc., Somerset Pharmaceuticals, Inc. and Barr Laboratories, Inc. Dr. Bell is an Adjunct Professor of Pharmaceutics, National Advisory Board Member and recipient of the Distinguished Alumnus Award from the College of Pharmacy at the University of Florida and Affiliate Faculty at the College of Pharmacy at Virginia Commonwealth University. Dr. Bell has published and presented extensively and has been issued eight patents. Research interests include pharmaceutical and biomedical analysis, CMC, quality, vaccines, biosimilar proteins, women’s health products, oncology therapeutics, drug addiction treatment and green pharmaceutical chemistry initiatives.

Dr. Bell has served in various leadership capacities within the American Association of Pharmaceutical Scientists (AAPS) including Chair of the Analysis and Pharmaceutical Quality (APQ) section, Editorial Advisory Board for the Journal of Pharmaceutical and Biomedical Analysis, reviewer for AAPS PharmSciTech and AAPS Journal, 2006 National Biotechnology Conference Chair, AAPS Executive Council Member-At-Large (2009), and the 2010 Chair of the Americas for the joint Pharmaceutical Sciences World Congress / FIP /AAPS Annual Meeting. Dr. Bell recently chaired the AAPS Blog Committee and blogs on a regular basis.

Dr. Bell is a Member of the Council of Experts, General Chapters-Biological Analysis and the Joint Standards Subcommittee for United States Pharmacopeia, Editorial Advisory Board Member for the Journal of Chemical and Pharmaceutical Sciences and Enliven: Biosimilars and Bioavailability, Co-Editor for the book Poorly Soluble Drugs: Dissolution and Drug Release. Dr. Bell participated as a member of the American Society of Clinical Oncology, American Urology Association, American Chemical Society and the American College of Clinical Pharmacology, and the Visiting Scientist Program to universities, colleges and high schools.


Timothy J. Foley: As a business and operations strategist for the healthcare industry and former president of Cardiac Rhythm Associates of New Jersey, Tim has focused his career on developing solutions designed to support patients and caregivers. Prior to joining Cardiac Rhythm Associates, Tim served as a Territory Manager and Consultant for Guidant, which was acquired by Boston Scientific and St. Jude Medical in their Cardiac Units. Tim started his sales and marketing career with Merck where he launched numerous products. Tim earned his B.S. in Accounting from LaSalle University and an M.S. and M.B.A. from the New Jersey Institute of Technology.


David Hassrick: an environmental consultant who has been providing environmental liability analysis for corporations across North America. Dave's primary practice area has focused on re-positioning of an environmentally impaired real estate and working with global companies to improve their environmental footprint for long-term growth and sustainability.



Robert Kamerschen: Mr. Kamerschen is a very successful change and transformation leader in a number of sales and marketing driven industries, a highly experienced outside director of public and private companies and personal investor. From 1988 until 1999, Mr. Kamerschen served as Chairman and Chief Executive Officer of ADVO, Inc., the nation's largest direct mail microtargeting services company with $1 billion in annual revenue (NYSE). Mr. Kamerschen has also served as CEO of DIMAC, Inc., RKO/Six Flags Entertainment, Inc., and Max Factor, Inc. He has also been EVP-Group Executive of Norton Simon, Inc. overseeing five major companies as well as President of Marketing Corporation of America and Chanel Inc. Finally, he has served in senior level marketing and sales positions at Revlon, Inc., Dunkin Donuts, Inc. and Scott Paper Company. Mr. Kamerschen is currently on the Board of Directors of MDC Partners, Inc. (NASDAQ and TSE) along with several private companies. He has previously served on a number of public boards including RadioShack (NYSE), Linens n Things (NYSE), Vertrue, Inc. (NASDAQ), IMS Health (NYSE), R. H. Donnelley (NYSE) and Playboy Enterprises (NYSE) among others.


Leslie V. Norwalk, Esq.: Leslie Norwalk is Strategic Counsel to Epstein Becker Green, P.C., EBG Advisors and National Health Advisors.  She serves as an advisor to three private equity firms: Warburg Pincus, Peloton Equity, and Enhanced Equity Fund; and currently sits on the boards of directors of NuVasive, Endologix, Providence Service Corp.,  Cedar Gate, Abode Healthcare, HPOne, Linkwell Health and MedCircle.  She is also a member of APCO Worldwide's International Advisory Council.

Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS).  She managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of health care facilities and other federal health care initiatives. For four years prior to that, she was the agency's Deputy Administrator, responsible for the implementation of the hundreds of changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit.

CMS has the second-largest budget outlay of the Federal Government, directly responsible for $1 out of every $3 spent on healthcare in the United States. The organization insures approximately a third of the population of the United States (more than 100 million beneficiaries) including the elderly, disabled, and some of the lowest income individuals in the country. CMS processes over one billion claims each year and contracts with approximately one million providers.

Prior to serving the Bush Administration, she practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. where she advised clients on a variety of health policy matters. She also served in the first Bush administration in the White House Office of Presidential Personnel, and the Office of the U.S. Trade Representative.

Ms. Norwalk, a native of Dayton, OH, earned a juris doctor degree from the George Mason University School of Law, where she was a Dean's Scholar and an editor of the George Mason Law Review. She earned a bachelor's degree, cum laude, in economics and international relations from Wellesley College.


Dr. John O'Connell graduated from Central Michigan University in 1983 with a B.S. in chemistry, mathematics and computer science. He graduated from the University of California, Berkeley in 1988 with a Ph.D. in synthetic organic and computational chemistry with Professor Henry Rapoport.  He continued at Berkeley as a post-doctoral research associate in synthetic organic chemistry until 1990.  He then was a post-doctoral research associate at the Eidgenössische Technische Hochschule (ETH) (Swiss Federal Institute of Technology), Zurich, Switzerland as a NIH (National Institutes of Health) and Glaxo post-doctoral fellow with Professor Kurt Wüthrich (Nobel Prize Chemistry 2002) until 1992 in structural biology, biophysics and protein nuclear magnetic resonance (NMR).

Thereafter, John spent seven years at Merck Research Laboratories (Merck & Co.) as a senior research scientist in biomedical research in the areas of biophysics, structural biology, computational chemistry, high-performance computing (HPC) and multi-nuclear/multi-dimensional protein NMR.  In all of these roles, John was responsible for designing and maintaining the high-performance computing platforms to support the scientific research.

In 1999, John joined Bloomberg L.P. as a senior technical manager.  In this capacity, he developed the backend processing system (1000+ firms daily, considered the largest in the world) and which allowed for later 24 hour trading, and was the architect and developer of, both the Bloomberg compliance system (CMPX, 400+ firms) and the mortgage EPN/TBA (electronic pool notification, to be announced, > $18 billion per month) system.  Projects involved design of large-scale server architecture, database schema and administration and real-time, mission-critical applications with numerous trading system functionalities. 

In 2011 he joined R-Squared Services & Solutions in a principle officer position as Chief Software Architect. Previously he was one of a very small group of outside investors in the firm. R-Squared was a leading software company that provided healthcare and life sciences companies with powerful ways to assure compliance with the web of laws and regulations affecting them. Clients were mostly Fortune 20 medical device manufactures that used a suite of applications for legal transparency/compliance and CMS reporting. His role was to assist in the development of  RADS® compliance platform and to develop the  CIR2US® system for customer master/master data management, itemized expenses and high-speed searching which comprised the backend for all the R-Squared's applications. Software architecture and development included high-performance searching servers, database schema and administration and internal/external web interfaces.


Matthew T. Riccio: Matthew is a Doctoral Candidate and Adjunct Instructor at New York University, as well as a National Science Foundation Graduate Research Fellow.  Matt's research explores the social cognitive and perceptual processes that predict and promote effective health-relevant behavior change and goal pursuit, focusing primarily on the ways that motivational states and social support processes can facilitate self- and social-regulation in the health domain.  His work has been published in numerous peer-reviewed academic journals, as well as in representative media coverage on Yahoo! Health, MSN, Women's Health, Huffington Post, and TEDxNewYork, among others.


Join the community!

You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.